Antithrombin Alfa (ATryn®) Therapy in Hereditary Antithrombin (AT) Deficient Patients: A Phase 3 Study of Prophylactic Intravenous Administration in High Risk Situations

[No Value] Tiede A, J, Tait RC, Shaffer D, Baudo F, Boneu B, Dempfle C, Horellou M, Klamroth R, Lazarchick, AD Mumford, [No Value] Schulman S, Bonfiglio J, Frieling J, Conard J, von Depka M.

Research output: Contribution to journalArticle (Academic Journal)peer-review

Translated title of the contributionAntithrombin Alfa (ATryn®) Therapy in Hereditary Antithrombin (AT) Deficient Patients: A Phase 3 Study of Prophylactic Intravenous Administration in High Risk Situations
Original languageEnglish
Pages (from-to)616 - 612
JournalThrombosis and Haemostasis
Volume99
Publication statusPublished - 2008

Cite this